Freedman Lori 4
4 · Organogenesis Holdings Inc. · Filed Jun 6, 2025
Insider Transaction Report
Form 4
Freedman Lori
Chief Admin. and Legal Officer
Transactions
- Purchase
Class A Common Stock
2025-06-05$2.91/sh+142,379$413,625→ 837,437 total - Purchase
Class A Common Stock
2025-06-04$2.82/sh+100,863$284,716→ 695,058 total - Purchase
Class A Common Stock
2025-06-06$2.99/sh+9,022$26,949→ 846,459 total
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.74 to $2.875, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
- [F2]The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.815 to $2.98, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4.
- [F3]The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.945 to $3.00, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (3) to this Form 4.